Since improper targeting of pendrin was observed in almost all differentiated thyroid carcinomas and since pendrin mRNA and protein expression were comparable to noncancerous thyroid tissues, one may speculate that this is a general phenomenon of trafficking of pendrin in thyroid neoplasm. The gene discussed is SLC26A4; the disease is thyroid gland carcinoma.